Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019. Total revenues increased 76% to $1.51 billion. You may […]
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019. Total revenues increased 76% to $1.51 billion. You may […]
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020.
On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019.
Total revenues increased 76% to $1.51 billion.
You may also like:
